Mouse IFN-alpha / beta R1 Antibody Summary
Glu27-Thr429
Accession # P33896
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Limitin Inhibition of EMCV-induced Cytopathy and Neutralization by Mouse IFN‑ alpha / beta R1 Antibody. Recombinant Mouse Limitin (Catalog # 1535-LM) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the L-929 mouse fibroblast cell line in a dose-dependent manner (orange line). Inhibition of EMCV activity elicited by Recombinant Mouse Limitin (30 pg/mL) is neutralized (green line) by increasing concentrations of Mouse IFN-a/ beta R1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3039). The ND50 is typically 1-4 µg/mL.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IFN-alpha/beta R1
IFN-alpha / beta R1, also known as IFNAR1, belongs to the class II cytokine receptor family of proteins. Class II cytokine receptors form heterodimeric receptor complexes that mediate class II cytokine signals. Subunits of the different receptor complexes are shared and serve multiple functions (1-3). IFN-alpha / beta R1, in association with IFN-alpha / beta R2, is required for propagating antiviral signal transduction triggered by IFN-alpha and IFN-beta (4, 5). The mouse IFN-alpha / beta R1 cDNA encodes a 590 amino acid (aa) precursor including a 26 aa signal sequence, a 403 aa extracellular domain (ECD), a 20 aa transmembrane segment, and a 141 aa cytoplasmic domain (6). The ECD contains three tandem fibronectin type III repeats and is extensively glycosylated. The ECD of mouse IFN-alpha / beta R1 shares 47-48% aa identity with that of human, bovine, porcine, and ovine IFN-alpha / beta R1. IFN-alpha / beta R1 interacts very weakly or not at all with type 1 interferons and does not stably interact with IFN-alpha / beta R2. Ligands associate with IFN-alpha / beta R2, and this complex subsequently forms a stable ternary assembly with IFN-alpha / beta R1 (7, 8). IFN-alpha / beta R1 also associates with IFN-gamma R2 even in the absence of IFN-gamma stimulation (5). Tyrosine phosphorylation within the juxtamembrane cytoplasmic domain of IFN-alpha / beta R1 provides a docking site for the SH2 domains of Tyk2 and STAT2 (9-11). Tyk2 can directly phosphorylate IFN-alpha / beta R1 (10). Tyk2 also increases the level of cell surface expression of IFN-alpha / beta R1 by preventing constitutive internalization (12). Human IFN-alpha / beta R1 contains a nuclear localization signal in its ECD which is required for receptor translocation to the nucleus following interaction with ligand (13).
- Langer, J.A. et al. (2004) Cytokine Growth Factor Rev. 15:33.
- Kotenko, S.V. and J.A. Langer (2004) Int. Immunopharmacol. 4:593.
- Donnelly, R.P. et al. (2004) J. Leukoc. Biol. 76:314.
- Hwang, S.Y. et al. (1995) Proc. Natl. Acad. Sci. USA 92:11284.
- Takaoka, A. et al. (2000) Science 288:2357.
- Uze, G. et al. (1992) Proc. Natl. Acad. Sci. USA 89:4774.
- Lamken, P. et al. (2004) J. Mol. Biol. 341:303.
- Arduini, R.M. et al. (1999) Prot. Sci. 8:1867.
- Krishnan, K. et al. (1998) J. Biol. Chem. 273:19495.
- Yan, H. et al. (1996) Mol. Cell. Biol. 16:2074.
- Yan, H. et al. (1996) EMBO J. 15:1064.
- Ragimbeau, J. et al. (2003) EMBO J. 22:537.
- Subramaniam, P.S. and H.M. Johnson (2004) FEBS Lett. 578:207.
Product Datasheets
Citations for Mouse IFN-alpha / beta R1 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
5
Citations: Showing 1 - 5
Filter your results:
Filter by:
-
Hes1 attenuates type I IFN responses via VEGF-C and WDFY1
Authors: Ning F, Li X, Yu L et al.
Journal of Experimental Medicine
-
UBXN3B Controls Immunopathogenesis of Arthritogenic Alphaviruses by Maintaining Hematopoietic Homeostasis
Authors: T Geng, D Yang, T Lin, JG Cahoon, P Wang
MBio, 2022-11-15;0(0):e0268722.
Species: Mouse
Sample Types: Whole Cells
Applications: Neutralization -
Hes1 attenuates type I IFN responses via VEGF-C and WDFY1
Authors: Ning F, Li X, Yu L et al.
Journal of Experimental Medicine
-
Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.
Authors: Vanhoutte F, Paget C, Breuilh L, Fontaine J, Vendeville C, Goriely S, Ryffel B, Faveeuw C, Trottein F
Immunol. Lett., 2007-12-17;116(1):86-94.
Species: Mouse
Sample Types: Whole Cells
Applications: Neutralization -
Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon beta -mediated suppression of immune checkpoint receptor expression
Authors: Donghwan Jeon, Douglas G. McNeel
OncoImmunology
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Mouse IFN-alpha / beta R1 Antibody
There are currently no reviews for this product. Be the first to review Mouse IFN-alpha / beta R1 Antibody and earn rewards!
Have you used Mouse IFN-alpha / beta R1 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image